Page 3 - CIRN-AR-2015-PRESS.indd
P. 3
Letter from the Management Committee
th
We are pleased to provide this, our 5 PCIRN/CIRN • Serious Outcomes Surveillance Network, led by Drs.
Annual Report, with an array of information on both Shelly McNeil and Melissa Andrew
our concluding PCIRN projects and our newly launched • Provincial Collaborative Network, led by Drs. Natasha
CIRN research programs. CIRN has been established to Crowcroft and Jeff Kwong
provide Canada with a national capacity to undertake • Special Immunization Clinics Network, led by Drs.
coordinated, evaluative research to inform public health Gaston De Serres and Karina Top
policy relating to vaccines and vaccination.
The three support networks undertaking independent
CIRN’s goals remain largely consistent with that of research and working to assist the core infrastructures
PCIRN; however, CIRN’s mandate covers a broader are:
scope of research pertaining to all public health vaccines. • Modelling and Economics Research Network, led by
Dr. Marc Brisson
Our goals are to: • Reference Laboratory Network, led by Dr. Brian Ward
• Continue to perform vaccine research to inform • Social Sciences and Humanities Network, led by Dr.
health policy in Canada. Eve Dubé
• Maintain an active research network capable of
immediate response to infectious disease threats in The process for selecting 2015 to 2016 projects is
Canada. actively underway at CIRN, and 15 new projects have
• Perform applied public health research and vaccine been submitted for consideration by investigators across
evaluations of high priority for Canadian public the network. In 2015, PCIRN enters its last year of
health decision makers. funding and many of our PCIRN-specifi c projects will be
• Further develop collaborations between Canadian concluding; however, our existing PCIRN infrastructures
vaccine experts. will be in large part retained and expanded to support
• Train the next generation of vaccine researchers. the new and broader mandate of CIRN. We look forward
to generating important new data to form health policy
CIRN continues to operate as a “network of networks” as we continue to build this important network.
with fi ve core infrastructure networks:
• Clinical Trials Network, led by Dr. Joanne Langley
• Canadian National Vaccine Safety Network, led by
Dr. Julie Bettinger
CIRN Management Committee, April 2015
Dr. Scott Halperin Dr. Gaston De Serres Dr. Mark Loeb
Dr. Shelly McNeil Dr. Karina Top Dr. Philippe De Wals
Dr. Joanne Langley Dr. Brian Ward Dr. Shelley Deeks
Dr. Julie Bettinger Dr. Eve Dubé Gina Charos representing the
Dr. Natasha Crowcroft Dr. Marc Brisson Public Health Agency of Canada
Dr. Jeff Kwong Dr. David Sheifele
2015 ANNUAL REPORT 1
th
We are pleased to provide this, our 5 PCIRN/CIRN • Serious Outcomes Surveillance Network, led by Drs.
Annual Report, with an array of information on both Shelly McNeil and Melissa Andrew
our concluding PCIRN projects and our newly launched • Provincial Collaborative Network, led by Drs. Natasha
CIRN research programs. CIRN has been established to Crowcroft and Jeff Kwong
provide Canada with a national capacity to undertake • Special Immunization Clinics Network, led by Drs.
coordinated, evaluative research to inform public health Gaston De Serres and Karina Top
policy relating to vaccines and vaccination.
The three support networks undertaking independent
CIRN’s goals remain largely consistent with that of research and working to assist the core infrastructures
PCIRN; however, CIRN’s mandate covers a broader are:
scope of research pertaining to all public health vaccines. • Modelling and Economics Research Network, led by
Dr. Marc Brisson
Our goals are to: • Reference Laboratory Network, led by Dr. Brian Ward
• Continue to perform vaccine research to inform • Social Sciences and Humanities Network, led by Dr.
health policy in Canada. Eve Dubé
• Maintain an active research network capable of
immediate response to infectious disease threats in The process for selecting 2015 to 2016 projects is
Canada. actively underway at CIRN, and 15 new projects have
• Perform applied public health research and vaccine been submitted for consideration by investigators across
evaluations of high priority for Canadian public the network. In 2015, PCIRN enters its last year of
health decision makers. funding and many of our PCIRN-specifi c projects will be
• Further develop collaborations between Canadian concluding; however, our existing PCIRN infrastructures
vaccine experts. will be in large part retained and expanded to support
• Train the next generation of vaccine researchers. the new and broader mandate of CIRN. We look forward
to generating important new data to form health policy
CIRN continues to operate as a “network of networks” as we continue to build this important network.
with fi ve core infrastructure networks:
• Clinical Trials Network, led by Dr. Joanne Langley
• Canadian National Vaccine Safety Network, led by
Dr. Julie Bettinger
CIRN Management Committee, April 2015
Dr. Scott Halperin Dr. Gaston De Serres Dr. Mark Loeb
Dr. Shelly McNeil Dr. Karina Top Dr. Philippe De Wals
Dr. Joanne Langley Dr. Brian Ward Dr. Shelley Deeks
Dr. Julie Bettinger Dr. Eve Dubé Gina Charos representing the
Dr. Natasha Crowcroft Dr. Marc Brisson Public Health Agency of Canada
Dr. Jeff Kwong Dr. David Sheifele
2015 ANNUAL REPORT 1
